NO20021503L - quinazolinones - Google Patents
quinazolinonesInfo
- Publication number
- NO20021503L NO20021503L NO20021503A NO20021503A NO20021503L NO 20021503 L NO20021503 L NO 20021503L NO 20021503 A NO20021503 A NO 20021503A NO 20021503 A NO20021503 A NO 20021503A NO 20021503 L NO20021503 L NO 20021503L
- Authority
- NO
- Norway
- Prior art keywords
- quinazolinones
- solvates
- salts
- formula
- set forth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Kinazolinoner med formel (I) hvor R, R1, R2, R3 Y, n og m har betydningene angitt i patentkrav l, og deres salter eller solvater som glyko- protein IblX-antagonister.Quinazolinones of formula (I) wherein R, R1, R2, R3 Y, n and m have the meanings set forth in claim 1, and their salts or solvates as glycoprotein IblX antagonists.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40793999A | 1999-09-28 | 1999-09-28 | |
PCT/EP2000/008939 WO2001023364A1 (en) | 1999-09-28 | 2000-09-13 | Quinazolinones |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20021503L true NO20021503L (en) | 2002-03-26 |
NO20021503D0 NO20021503D0 (en) | 2002-03-26 |
Family
ID=23614192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20021503A NO20021503D0 (en) | 1999-09-28 | 2002-03-26 | quinazolinones |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1216233A1 (en) |
KR (1) | KR20020047185A (en) |
AR (1) | AR025796A1 (en) |
AU (1) | AU7419300A (en) |
BR (1) | BR0014311A (en) |
CA (1) | CA2385918A1 (en) |
NO (1) | NO20021503D0 (en) |
WO (1) | WO2001023364A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7671200B2 (en) | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
JP4887139B2 (en) | 2003-03-25 | 2012-02-29 | 武田薬品工業株式会社 | Dipeptidyl peptidase inhibitor |
RU2006107553A (en) | 2003-08-13 | 2007-09-20 | Такеда Фармасьютикал Компани Лимитед (Jp) | 4-Pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
EP1699777B1 (en) | 2003-09-08 | 2012-12-12 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
NZ549716A (en) | 2004-03-15 | 2010-04-30 | Takeda Pharmaceutical | Pyrimidin-dione derivatives as dipeptidyl peptidase inhibitors |
WO2006068978A2 (en) | 2004-12-21 | 2006-06-29 | Takeda Pharmaceutial Company Limited | Dipeptidyl peptidase inhibitors |
NZ566799A (en) | 2005-09-14 | 2011-04-29 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors for treating diabetes |
CN101360723A (en) | 2005-09-16 | 2009-02-04 | 武田药品工业株式会社 | Process for the preparation of pyrimidinedione derivatives |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5783577A (en) * | 1995-09-15 | 1998-07-21 | Trega Biosciences, Inc. | Synthesis of quinazolinone libraries and derivatives thereof |
-
2000
- 2000-09-13 CA CA002385918A patent/CA2385918A1/en not_active Abandoned
- 2000-09-13 AU AU74193/00A patent/AU7419300A/en not_active Abandoned
- 2000-09-13 WO PCT/EP2000/008939 patent/WO2001023364A1/en not_active Application Discontinuation
- 2000-09-13 EP EP00962482A patent/EP1216233A1/en not_active Withdrawn
- 2000-09-13 BR BR0014311-1A patent/BR0014311A/en not_active Application Discontinuation
- 2000-09-13 KR KR1020027003906A patent/KR20020047185A/en not_active Application Discontinuation
- 2000-09-27 AR ARP000105075A patent/AR025796A1/en unknown
-
2002
- 2002-03-26 NO NO20021503A patent/NO20021503D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR025796A1 (en) | 2002-12-11 |
WO2001023364A1 (en) | 2001-04-05 |
EP1216233A1 (en) | 2002-06-26 |
CA2385918A1 (en) | 2001-04-05 |
BR0014311A (en) | 2002-05-21 |
KR20020047185A (en) | 2002-06-21 |
AU7419300A (en) | 2001-04-30 |
NO20021503D0 (en) | 2002-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199801255T2 (en) | Vitronectin receptor antagonists. | |
ATE469892T1 (en) | SUBSTITUTED 1H-DIHYDROPYRAZOLES, THEIR PREPARATION AND USE | |
NO20006282L (en) | New cyclosporins | |
ATE416157T1 (en) | INHIBITORS OF INTEGRIN ALPHA-V-BETA-6 | |
NO20021503L (en) | quinazolinones | |
MY121136A (en) | Novel heterocyclic sulfonamides. | |
DK0937074T3 (en) | Benzonaphthyridines as bronchial therapeutics | |
NO991761L (en) | New piperidine cotocarboxylic acid derivatives, their preparation and use | |
NO20005264D0 (en) | Heterocyclic substituted amides, their preparation and use | |
SE9702773D0 (en) | Novel compounds | |
DK1042319T3 (en) | dihydrobenzofuranes | |
DK0810991T3 (en) | 1-Aryl-2-acylamino-ethane compounds and their use as neurokinin, especially neurokinin-1 antagonists | |
MY136297A (en) | Piperazine derivatives having sst1 antagonistic activity | |
NO20001934L (en) | 3-Substituted tetrahydropyridopyrimidinone derivatives, their preparation and use | |
NO20022123L (en) | Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII | |
NO20002124L (en) | Novel Carboxylic Acid Derivatives with Amide Side Chains, Their Preparation and Use as Endothelin Receptor Antagonists | |
NO20021502L (en) | quinazolinones | |
DK1204659T3 (en) | Serotonergic benzofurans | |
NO20020885L (en) | <Alpha> v <beta> 3-integrin | |
TR199901416T2 (en) | Heterocyclic carbonicacyte térevleri. | |
TR199903159T2 (en) | New �-Amino and �-Azido carbonic acid derivatives. | |
NO20001077L (en) | Novel Carboxylic Acid Derivatives, Their Preparation and Use as Mixed ETA / ETB Endothelin Receptor Antagonists | |
NO20010626D0 (en) | N-substituted azabicycloheptane derivatives, their preparation and use | |
NO20000324L (en) | Benzotia (oxa) diazole derivatives and their use as endothelin receptor antagonists | |
NO20002154L (en) | Novel heterocyclic substituted alpha hydroxycarboxylic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |